Source:http://linkedlifedata.com/resource/pubmed/id/21094171
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5-6
|
pubmed:dateCreated |
2011-1-24
|
pubmed:abstractText |
Treatment of cachexia requires pharmacological intervention which, in turn, requires knowledge of the mediators and processes. Cachexia markers that are specifically expressed in pancreatic cancer and secreted into the blood circulation have yet to be identified. The aim of our study was to investigate the serum protein profiles and protein alterations associated with cachexia and to identify potential disease protein biomarkers indicative for this syndrome.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1879-0631
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright © 2010 Elsevier Inc. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:day |
31
|
pubmed:volume |
88
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
218-25
|
pubmed:meshHeading |
pubmed-meshheading:21094171-Adult,
pubmed-meshheading:21094171-Aged,
pubmed-meshheading:21094171-Biological Markers,
pubmed-meshheading:21094171-Blood Proteins,
pubmed-meshheading:21094171-Cachexia,
pubmed-meshheading:21094171-Databases, Protein,
pubmed-meshheading:21094171-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:21094171-Female,
pubmed-meshheading:21094171-Humans,
pubmed-meshheading:21094171-Immunohistochemistry,
pubmed-meshheading:21094171-Male,
pubmed-meshheading:21094171-Middle Aged,
pubmed-meshheading:21094171-Pancreatic Neoplasms
|
pubmed:year |
2011
|
pubmed:articleTitle |
Identification of serum proteins involved in pancreatic cancer cachexia.
|
pubmed:affiliation |
Department of General Surgery, University of Heidelberg, Germany. klaus.felix@med.uni-heidelberg.de
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|